MedTrace Logo

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

NCT04703166 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2026-05-19

No results posted yet for this study

Summary

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

Conditions

Interventions

DEVICE

Samsung Galaxy Watch Active2

The Samsung wearable device will collect data; photoplethysmography (PPG) waveforms, heart rate, heart rate variability, step counts, oxygen saturation levels, sleep pattern and quality.

Sponsors & Collaborators

  • Samsung

    collaborator INDUSTRY

  • Preventice

    collaborator INDUSTRY

  • Tulane University School of Medicine

    lead OTHER

Principal Investigators

  • Nassir F Marrouche, MD · Tulane University School of Medicine

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-08
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04703166 on ClinicalTrials.gov